Comparison

EHP-101 European Partner

Item no. TMO-T13289-5mg
Manufacturer TargetMol
CASRN 1818428-24-8
Amount 5 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Format Powder
Specific against other
Purity 0,98
Smiles CCCCCC1=C(NCc2ccccc2)C(=O)C([C@@H]2C=C(C)CC[C@H]2C(C)=C)=C(O)C1=O
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias VCE-​004.8
Shipping Condition Cool pack
Available
Manufacturer - Targets
Cannabinoid Receptor|||HIF/HIF Prolyl-Hydroxylase|||PPAR
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
433.58
Description
EHP-101 (VCE-004.8) is a specific dual agonist of PPARγ and CB2 receptor with potent anti-inflammatory activity. EHP-101 attenuates adipogenesis and prevents diet-induced obesity.
Pathways
Metabolism|||DNA Damage/DNA Repair|||Chromatin/Epigenetic|||GPCR/G Protein

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 5 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close